# EDGAR Filing Document

**Accession Number:** 0001731348
**File Stem:** 0001437749-25-035739
**Filing Date:** 2025-11
**Character Count:** 6647
**Document Hash:** f041f84e7b042e2ef94c4bd6f5749827
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-25-035739.hdr.sgml**: 20251119

**ACCESSION NUMBER**: 0001437749-25-035739

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20251119

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20251119

**DATE AS OF CHANGE**: 20251119

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tilray Brands, Inc.
- **CENTRAL INDEX KEY:** 0001731348
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 824310622
- **FISCAL YEAR END:** 0531

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38594
- **FILM NUMBER:** 251499713

**BUSINESS ADDRESS:**
- **STREET 1:** 655 MADISON AVENUE
- **STREET 2:** 19TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10065
- **BUSINESS PHONE:** 519.322.8800

**MAIL ADDRESS:**
- **STREET 1:** 655 MADISON AVENUE
- **STREET 2:** 19TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10065

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Tilray, Inc.
- **DATE OF NAME CHANGE:** 20180213

?xml version='1.0' encoding='ASCII'? tlry20251113_8k.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM**8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):**November 19, 2025**

**Tilray Brands, Inc.**

**(Exact name of Registrant as Specified in Its Charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-38594** | **82-4310622** |
| **(State or Other Jurisdiction** | **(Commission File** | **(IRS Employer** |
| **of Incorporation)** | **Number)** | **Identification No.)** |
| &nbsp;&nbsp;&nbsp;&nbsp; **265 Talbot Street West,** |  |  |
| **Leamington,**ON** |  | **N8H 5L4** |
| **(Address of Principal Executive Offices,** |  | **(Zip Code)** |

---

Registrant's Telephone Number, Including Area Code: **(**844**)**845-7291**

**Not applicable**

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Name of each exchange on which registered** |
|  | **Symbol(s)** |  |
| **Common Stock, $0.0001 par** | **TLRY** |  |
| **value per share** |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **The**Nasdaq** Global Select Market** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.07 Submission of Matters to a Vote of Security Holders.**

On November 18, 2025, Tilray Brands, Inc. (the "**Company**") held its 2025 annual meeting of stockholders (the "**Annual Meeting**"**),** at which a quorum was present.

At the Annual Meeting, stockholders considered and voted on the following proposals, each of which is described in more detail in the Company's proxy statement dated September 26, 2025 (the "**Proxy Statement**"): (1) the re-election of John Herhalt as the Class I director to serve until his term expires or until a successor is duly elected and qualified; (2) the ratification of the appointment of PricewaterhouseCoopers LLP ("**PWC**") as the Company's independent registered accounting firm for the current fiscal year; (3) approval of the non-binding advisory resolution on the named executive officer compensation; and (4) the approval of the amendments (the "**Governance Changes Proposal**") to the Company's Certificate of Incorporation, as amended, to declassify the Company's Board of Directors and eliminate provisions that allow stockholders to remove directors only for cause.

Each of the first and second proposals were formally approved and the third proposal was supported by approximately 70% of the vote of the Company's stockholders at the Annual Meeting, as detailed in the voting results outlined below.

The fourth proposal did not receive sufficient votes cast to approve the Governance Changes Proposal (i.e., majority of outstanding shares).

***Proposal No. 1*** – ***Election of the Class I Director:***

---

| | | | |
|:---|:---|:---|:---|
| **Nominee** | **For** | **Withheld** | **Broker**<br> **Non-Votes** |
| John Herhalt | 85540003 | 23,445,500 | 326,877,556 |

---

------

***Proposal No. 2*** – ***Ratification of Selection of PWC as Independent Registered Public Accounting Firm:***

---

| | |
|:---|:---|
| **For** | 402,964,551 |
| **Against** | 20,170,494 |
| **Abstain** | 12,728,014 |

---

------

***Proposal No. 3*** – ***Voting Results for the Non-Binding Advisory Resolution on the Named Executive Officer Compensation:***

---

| | |
|:---|:---|
| **For** | 72,869,843 |
| **Against** | 31,887,041 |
| **Abstain** | 4,228,619 |

---

------

***Proposal No. 4*** – ***Governance Changes Proposal:***

---

| | |
|:---|:---|
| **For** | 93,618,416 |
| **Against** | 12,215,984 |
| **Abstain** | 3,151,103 |
| **Broker Non-Votes** | 326,877,556 |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

**Tilray Brands, Inc.**

Date: November 19, 2025

By: <u>/s/ Mitchell Gendel</u>

Name: Mitchell Gendel

Title: Global General Counsel